First FDA-approved Treatment for Desmoid Tumors
The FDA has approved nirogacestat for the treatment of noncancerous but painful growths called desmoid tumors. The U.S. Food...
The FDA has approved nirogacestat for the treatment of noncancerous but painful growths called desmoid tumors. The U.S. Food...
the immunotherapeutic pembrolizumab in combination with chemotherapy WAS APPROVED to treat certain adult patients with esophageal cancer. The U.S....
The U.S. FDA approved a molecularly targeted therapeutic to treat certain patients with cholangiocarcinoma. The U.S. Food and Drug...
PHILADELPHIA – T-cell responses directed against the receptor-binding domain of the SARS-CoV-2 spike protein were associated with protection from...
SAN DIEGO – A video designed to educate Black men about prostate cancer resulted in 97% of surveyed participants...
PHILADELPHIA — The American Association for Cancer Research (AACR) today announced the opening of the submission site for its...
SAN ANTONIO – In patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of the investigational...
SAN ANTONIO – Survivors of early-stage breast cancer who participated in a lifestyle intervention on healthy habits lost weight...
SAN DIEGO – An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with...
Clinical benefit was independent of patients’ tumor mutational burden ORLANDO, Fla. – mRNA-4157/V940, a personalized mRNA-based cancer vaccine,...
PHILADELPHIA – Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab (Opdivo) plus ipilimumab (Yervoy)...
PHILADELPHIA – The American Association for Cancer Research (AACR) is pleased to announce the recipients of the 2023 AACR...
NEW ORLEANS – An artificial intelligence (AI) model trained using sequential health information derived from electronic health records identified...
Mutations were detected via circulating tumor DNA before disease progression in patients treated with an aromatase inhibitor/palbociclib for hormone...
Study reports five-year survival outcomes PHILADELPHIA – Patients with resectable non-small cell lung cancer (NSCLC) who were treated with...
Study reports the landscape of mutations present in pediatric acute lymphoblastic leukemia (ALL) and how this landscape changes during...
World’s leading cancer research experts from Philadelphia’s largest health care and academic institutions will unite for a live, interactive...
Submission deadline is November 12 PHILADELPHIA – The American Association for Cancer Research (AACR) announces the call for entries...
PHILADELPHIA — The American Association for Cancer Research (AACR) is pleased to announce the recipients of the 2020 AACR...
Awardees to be recognized at the AACR Annual Meeting 2023 in Orlando PHILADELPHIA – The American Association for Cancer...
Awardees will receive $5,000 unrestricted cash prize PHILADELPHIA – The American Association for Cancer Research (AACR) is inviting journalists...
Cash Prize of $5,000 in Each of the Six Categories PHILADELPHIA – The submission deadline for the American Association...
CHARLOTTE, North Carolina – The American Association for Cancer Research will host a conference titled Environmental Carcinogenesis: Potential Pathway...
SAN DIEGO – A blood-based machine learning assay that combines cell-free DNA (cfDNA) fragment patterns and levels of the...
SAN ANTONIO – Patients with invasive breast cancer who had low scores on an investigational gene molecular signature had...
NEW ORLEANS – A variant of the CTLA-4 gene associated with autoimmune disease was found to be more frequent...
Awardees to be recognized at the AACR Annual Meeting 2019 PHILADELPHIA – The American Association for Cancer Research (AACR)...
Tumor biology, not race, was a more significant factor in predicting response to clinical trial treatment SAN ANTONIO – Analysis...
Among patients over 65 who received an allogeneic hematopoietic stem cell transplant (allo-HCT) for the treatment of acute myeloid...
PHILADELPHIA – Baseline levels of circulating tumor DNA (ctDNA) predicted responses to first-line, but not second-line, immune checkpoint inhibition...